|
Title
|
|
|
|
Non-alcoholic steatohepatitis decreases microsomal liver function in the absence of fibrosis
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| The incidence of non-alcoholic fatty liver disease (NAFLD) is rising across the globe, with the presence of steatohepatitis leading to a more aggressive clinical course. Currently, the diagnosis of non-alcoholic steatohepatitis (NASH) is based on histology, though with the high prevalence of NAFLD, a non-invasive method is needed. The 13C-aminopyrine breath test (ABT) evaluates the microsomal liver function and could be a potential candidate. We aimed to evaluate a potential change in liver function in NASH patients and to evaluate the diagnostic power of ABT to detect NASH. We performed a retrospective analysis on patients suspected of NAFLD who underwent a liver biopsy and ABT. 440 patients were included. ABT did not decrease in patients with isolated liver steatosis but decreased significantly in the presence of NASH without fibrosis and decreased even further with the presence of significant fibrosis. The predictive power of ABT as a single test for NASH was low but improved in combination with ALT and ultrasonographic steatosis. We conclude that microsomal liver function of patients with NASH is significantly decreased, even in the absence of fibrosis. The ABT is thus a valuable tool in assessing the presence of NASH; and could be used as a supplementary diagnostic tool in clinical practice. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Biomedicines / Multidisciplinary Digital Publishing Institute. - 2013, currens
| |
|
Publication
|
|
|
|
2020
| |
|
ISSN
|
|
|
|
2227-9059
| |
|
DOI
|
|
|
|
10.3390/BIOMEDICINES8120546
| |
|
Volume/pages
|
|
|
|
8
:12
(2020)
, 16 p.
| |
|
Article Reference
|
|
|
|
546
| |
|
ISI
|
|
|
|
000601659700001
| |
|
Pubmed ID
|
|
|
|
33261113
| |
|
Medium
|
|
|
|
E-only publicatie
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|